Skip to content
  • Monday, 21 September 2026
  • 2:44 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Breaking the Neuroimaging Time Barrier: Johns Hopkins Researchers Unveil CloudScope to Monitor Brain Disease Over 24 Hours
Biotech & Genetic Research

Breaking the Neuroimaging Time Barrier: Johns Hopkins Researchers Unveil CloudScope to Monitor Brain Disease Over 24 Hours

Jia Lissa Sep 21, 2026 0

For decades, modern neuroscience has operated under a frustrating temporal constraint. While central nervous system disorders such as epilepsy, brain…

Read More
The Planet’s Chemical Genesis: New Research Reveals Crucial Oxygen Levels for Life’s EmergenceScientists Replicate Human Bone Marrow Architecture Using Only Human Cells to Advance Blood Cancer Research and Reduce Animal TestingThe Secret Chemical Language of Cats: How Feline Kidneys Encode Unique Identities Through Specialized Fatty AcidsPhysicists Leverage Artificial Intelligence to Uncover Hidden Laws of Motion in Complex Dusty Plasma Systems
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
Decoding the Explosive Origins of Chronic Myeloid Leukemia: A Landmark Study Unveils Unprecedented Cancer Cell Growth Rates Years Before DiagnosisBreaking the Neuroimaging Time Barrier: Johns Hopkins Researchers Unveil CloudScope to Monitor Brain Disease Over 24 HoursArtificial Intelligence Framework PACMAN Revolutionizes Nuclear Fusion Control by Subduing Millisecond Plasma InstabilitiesTelix Pharmaceuticals Agrees to Acquire ITM Isotope Technologies Munich in Landmark $2.35bn Radiopharmaceutical Megamerger
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Decoding the Explosive Origins of Chronic Myeloid Leukemia: A Landmark Study Unveils Unprecedented Cancer Cell Growth Rates Years Before Diagnosis
Dwi Wanna Sep 21, 2026
Biotech & Genetic Research
Breaking the Neuroimaging Time Barrier: Johns Hopkins Researchers Unveil CloudScope to Monitor Brain Disease Over 24 Hours
Jia Lissa Sep 21, 2026
Advanced Materials Science
Artificial Intelligence Framework PACMAN Revolutionizes Nuclear Fusion Control by Subduing Millisecond Plasma Instabilities
Nila Kartika Wati Sep 21, 2026
Pharmaceutical R&D
Telix Pharmaceuticals Agrees to Acquire ITM Isotope Technologies Munich in Landmark $2.35bn Radiopharmaceutical Megamerger
Teuku Ryan Sep 21, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ